“Crypto Will Get What It Wants”: Here’s Who Could Replace Gary Gensler at the SEC
https://www.marketwatch.com/bulletins/redirect/go?g=c2c55884-42a5-4532-b5bb-04b223159daa&mod=mw_rss_bulletins
HUTCHMED to receive milestone payment as Takeda launches FRUZAQLA for colorectal cancer treatment in Japan
(RTTNews) – HUTCHMED (China) Limited (HCM) announced that it will receive a milestone payment following the price approval and launch of FRUZAQLA (fruquintinib) 1 mg/5 mg capsules in Japan by…
Read more